Laurion Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.03 - $17.69 $83,055 - $122,131	6,904 Added 4.18%	171,887 $2.37 Million
Q4 2023 Feb 14, 2024	BUY	$9.68 - $15.37 $1.5 Million - $2.38 Million	154,849 Added 1528.01%	164,983 $2.41 Million
Q2 2023 Aug 14, 2023	SELL	$11.74 - $14.47 $57,126 - $70,411	-4,866 Reduced 32.44%	10,134 $120,000
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $14,321 - $16,786	763 Added 5.36%	15,000 $322,000
Q3 2022 Nov 14, 2022	SELL	$16.44 - $26.57 $12,543 - $20,272	-763 Reduced 5.09%	14,237 $285,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $17.9 $436,087 - $1.36 Million	-76,239 Reduced 83.56%	15,000 $269,000
Q1 2022 May 16, 2022	BUY	$9.12 - $17.47 $832,099 - $1.59 Million	91,239 New	91,239 $905,000

178

84M

144K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1.01B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.